Angelisun Pharmaceutical Company
- Business Type : Manufacturer
- Year Established : 2010
- Main Products : APIs, Intermediates,Camptothecin,Paclitaxel
- Country/Region : China
- Links : China Health & Medicines, China Pharmaceutical Chemicals,
Company Introduction
Profile
Angelisun (Chongqing) Pharmaceutical Co., Ltd. (shorten as Angelisun) is a high- tech enterprise committed to APIs, intermediates,researching new pharmaceutical manufacturing,as a subsidiary of ANGELISUN (CQ) Group, which located in Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China, with 1,200 square meters of R&D Center and about 30 acres of manufacturing plant.
Main Research Project
anti-tumor and cardiovascular drugs
discovery and research of new drugs (including synthesis, preparation and quality control)
custom synthesis , counseling service,applicant and register (including drugs , intermediates)
Our Team
Angelisun is managed by a team of skilled and experienced professionals bringing an understanding and empathy of the requirements of the pharmaceutical and synthesis related industries. Their combined expertise enables Angelisun to offer a wide range of specialist manufacturing and analytical skills, together with project management and customer service excellence.
Our Collaborator
SIMM(Shanghai Institute of Materia Medica)
Chongqing University
Chongqing Medical University
Southwest University
Fudan University
Shenyang Pharmaceutical University
Our Mission
To supply health care products that improve the quality of life for mankind.
Contact Information
- Contact Person : Liu
- Telephone : 86 - 023 - 68030926
- Fax Number : 86 - 023 - 68198123
- Address : D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China Chongqing Chongqing 400039 China
- Fax : 86 - 023 - 68198123
- Website : Visit website
Related Products:Angelisun Pharmaceutical Company
No advertising and no spamming please
Angelisun Pharmaceutical Company no reviews currently
No reviews currently, you may post the first one.